RecruitingNCT04330118
Origin and Function of Eosinophilic Polynuclear During DRESS Syndrome
Studying Drug reaction with eosinophilia and systemic symptoms
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital, Lille
- Principal Investigator
- Delphine Staumont-Salle, MD,PhDUniversity Hospital, Lille
- Enrollment
- 80 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2020 – 2026
Study locations (11)
- CH d'Arras, Arras, France
- CH de Boulogne, Boulogne-sur-Mer, France
- Assistance Publique - Hôpitaux de Paris - HENRI MONDOR, Créteil, France
- CH de Douai, Douai, France
- CH de Dunkerque, Dunkirk, France
- CH LENS, Lens, France
- Hop Claude Huriez Chr Lille, Lille, France
- Groupe Hospitalier de l'Institut Catholique de Lille, Lille, France
- CH de Roubaix, Roubaix, France
- Hôpital FOCH, Suresnes, France
- CH de Valenciennes, Valenciennes, France
Collaborators
Société de Dermatologie Française · Société de Recherche en Dermatologie
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04330118 on ClinicalTrials.govOther trials for Drug reaction with eosinophilia and systemic symptoms
Additional recruiting or active studies for the same condition.
See all trials for Drug reaction with eosinophilia and systemic symptoms →